About Daphne Pharmaceuticals Private Limited
Data last updated:
Daphne Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 22 January 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U51109KA2016PTC085487. Its GSTIN is 29AAFCD5906L1ZA (Karnataka).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Khusbu Yadav and Rohit Yadav.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2023, the company reported a revenue of ₹5.39 Lakh, a decline of 55% compared to the previous year. For the same year it recorded a net loss of ₹1.14 Lakh (net margin -21.2%) and EBITDA of -₹93,796 (EBITDA margin -17.4%). Revenue has declined at a compounded annual rate (CAGR) of 23% over three years and 10% over five years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website daphnepharma.co.in.
Company details
Contact details
Daphne Pharmaceuticals Private Limited's registered office is in Bangalore, Karnataka. Its website is daphnepharma.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address#1064 Triveni Road (Near Ms Ramaiah Bus Stop) 1st Stage 2nd Phase Gokula Extension, Mathikere, Bangalore, Karnataka, India – 560054
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Daphne Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Daphne Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Daphne Pharmaceuticals Private Limited, buy the company report.
Financials of Daphne Pharmaceuticals Private Limited
FY 2023 filings availableDaphne Pharmaceuticals Private Limited reported revenue of ₹5.39 Lakh (down 55% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 10% over five years, including a 55% fall in the latest year. EBITDA rose 62% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹93,796 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.14 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -17.4% | ||||
| Net Profit Margin | -21.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Daphne Pharmaceuticals Private Limited, buy the company report.
Board of directors of Daphne Pharmaceuticals Private Limited
Daphne Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Khusbu Yadav | Director | 09 Jun 2018 | 8 Years 4 Months | Current |
| Rohit Yadav | Director | 16 Mar 2020 | 6 Years 7 Months | Current |
Peer comparison
Daphne Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Fulbert Pharmaceuticals Private Limited | ₹5.44 Lakh (FY 2018) | 44.0% | Surat, Gujarat, India | |||
| Impaler Pharmaceuticals Private Limited | ₹5.42 Lakh (FY 2020) | -58.0% | Shah Bhavan Nagpur, Maharashtra, India | |||
| Daphne Pharmaceuticals Private Limitedthis company | ₹5.39 Lakh (FY 2023) | -₹1.14 Lakh | -21.2% | -55.0% | Bangalore, Karnataka, India | |
| Sunvet Homoeo Pharmaceuticals Private Limited | ₹5.35 Lakh (FY 2025) | -4.0% | West Bengal, India |
To see the full peer comparison of Daphne Pharmaceuticals Private Limited, buy the company report.
Auditor
Daphne Pharmaceuticals Private Limited is audited by SUBEK AGARWAL & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SUBEK AGARWAL & ASSOCIATES | FY 2021 | 328737E |
Shareholding
The shareholding of Daphne Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Daphne Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Daphne Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Daphne Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Daphne Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAFCD5906L1ZA | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Daphne Pharmaceuticals Private Limited, buy the company report.
Recent activity
Daphne Pharmaceuticals Private Limited has 4 board changes on record since 2018: 2 appointments and 2 cessations. The latest: Bablu Sharma ceased to be Director on 05 Feb 2025.
Frequently asked questions
Daphne Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 22 January 2016 (10+ years old) and is registered under CIN U51109KA2016PTC085487.
Daphne Pharmaceuticals has 2 current directors:
- Khusbu Yadav - Director
- Rohit Yadav - Director
The latest financial statements of Daphne Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Daphne Pharmaceuticals is 29AAFCD5906L1ZA, registered in Karnataka.
The CIN (Corporate Identification Number) of Daphne Pharmaceuticals is U51109KA2016PTC085487. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Daphne Pharmaceuticals was incorporated on 22 January 2016, making it 10+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Daphne Pharmaceuticals by revenue are Fulbert Pharmaceuticals Private Limited, Impaler Pharmaceuticals Private Limited, Sunvet Homoeo Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Bablu Sharma ceased to be Director on 05 Feb 2025. Rohit Yadav was appointed as Director on 16 Mar 2020. Rohit Yadav ceased to be Director on 11 Jun 2018. Daphne Pharmaceuticals has 4 board changes on record in total.
Daphne Pharmaceuticals can be reached through the website daphnepharma.co.in. Its registered office is in Bangalore, Karnataka, India.
The registered office of Daphne Pharmaceuticals is at #1064 Triveni Road Near Ms Ramaiah Bus Stop 1st Stage 2nd Phase Gokula Extension, Mathikere, Bangalore, Karnataka, India – 560054.
Daphne Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.